SCHEMBL10015419

SCHEMBL10015419

Cc1cccc(C)c1-c1ccc2c3c(-c4cc(-c5ccccc5)nc(-c5ccccc5)c4)c4cc5c6ccccc6c6cccc(c4c(-c4cc(-c7ccccc7)nc(-c7ccccc7)c4)c3c3cccc1c23)c65

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ADORA1 P30542 6/20 0.34
▸ ADORA2A P29274 5/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ KDM4E B2RXH2 6/20 0.33
▸ POLB P06746 3/20 0.33
▸ PPARG P37231 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ NR2E3 Q9Y5X4 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ AGTR1 P30556 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ HPGD P15428 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12179767 0.90 MEN1 (0.32) MEN1KMT2AADORA1ADORA2APTGER4
SCHEMBL10015399 0.81 CRHR1 (0.35) MEN1KMT2AADORA1ADORA2AKDM4E
SCHEMBL10015405 0.81 CYP1A1 (0.39) MEN1KMT2AADORA1ADORA2AKDM4E
SCHEMBL23349053 0.81 MEN1 (0.31) MEN1KMT2AADORA2AALDH1A1CYP1A2
SCHEMBL23349052 0.81 MEN1 (0.31) MEN1KMT2AADORA2AALDH1A1CYP1A2
SCHEMBL10015417 0.79 GRM5 (0.38) —
SCHEMBL23348927 0.78 ALDH1A1 (0.36) ALDH1A1
SCHEMBL22823938 0.78 ALDH1A1 (0.36) ALDH1A1
SCHEMBL22653046 0.78 ALDH1A1 (0.36) MEN1KMT2AADORA2AALDH1A1CYP1A2
SCHEMBL14139933 0.78 ALDH1A1 (0.35) MEN1KMT2AADORA2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190245152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-08-08 — — US disclosed
US-9315460-B2 Organic compound, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2016-04-19 — — US disclosed
US-9315460-B2 Organic compound, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2016-04-19 — — US disclosed
US-8940413-B2 Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2015-01-27 — — US disclosed
US-8940413-B2 Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2015-01-27 — — US disclosed
US-20140374738-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KK (JP) 2014-12-25 — — US disclosed
US-20140374738-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KK (JP) 2014-12-25 — — US disclosed
US-20120025183-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KABUSHIKI KAISHA (JP) 2012-02-02 — — US disclosed
US-20120025183-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KABUSHIKI KAISHA (JP) 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025183-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS ACE, ACE2, AGTR1 MEN1 3665/4885KMT2A 2118/4885ADORA1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback